Targeted Non-Invasive PET Imaging of PD-L1-Expressing Colon Cancer Using a Zirconium-89 Radiolabeled Anti-PD-L1 Antibody

被引:0
|
作者
Mulgaonkar, Aditi [2 ]
Hao, Guiyang [2 ]
Xiong, Yahong [2 ]
Tang, Haidong [1 ]
Nham, Kien [2 ]
Silvers, William [2 ]
Fu, Yang-Xin [1 ]
Sun, Xiankai [2 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Pathol, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Radiol, Dallas, TX 75390 USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
926
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Product review on the Anti-PD-L1 antibody atezolizumab
    Shah, Neil J.
    Kelly, William J.
    Liu, Stephen V.
    Choquette, Karin
    Spira, Alexander
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (02) : 269 - 276
  • [22] Product review: avelumab, an anti-PD-L1 antibody
    Collins, Julie M.
    Gulley, James L.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (04) : 891 - 908
  • [23] Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
    Brahmer, Julie R.
    Tykodi, Scott S.
    Chow, Laura Q. M.
    Hwu, Wen-Jen
    Topalian, Suzanne L.
    Hwu, Patrick
    Drake, Charles G.
    Camacho, Luis H.
    Kauh, John
    Odunsi, Kunle
    Pitot, Henry C.
    Hamid, Omid
    Bhatia, Shailender
    Martins, Renato
    Eaton, Keith
    Chen, Shuming
    Salay, Theresa M.
    Alaparthy, Suresh
    Grosso, Joseph F.
    Korman, Alan J.
    Parker, Susan M.
    Agrawal, Shruti
    Goldberg, Stacie M.
    Pardoll, Drew M.
    Gupta, Ashok
    Wigginton, Jon M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26): : 2455 - 2465
  • [24] Retreatment with anti-PD-1 antibody in non-small cell lung cancer patients previously treated with anti-PD-L1 antibody
    Fujita, Kohei
    Yamamoto, Yuki
    Kanai, Osamu
    Okamura, Misato
    Hashimoto, Masayuki
    Nakatani, Koichi
    Sawai, Satoru
    Mio, Tadashi
    THORACIC CANCER, 2020, 11 (01) : 15 - 18
  • [25] Basic study of immunoradiation therapy using anti-PD-L1 antibody
    Hara, Takamitsu
    Sato, Hiroo
    Suzuki, Yoshiyuki
    Ohno, Tatsuya
    Okazaki, Atsushi
    CANCER SCIENCE, 2022, 113 : 613 - 613
  • [26] Epitope characterization of an anti-PD-L1 antibody using orthogonal approaches
    Hao, Gang
    Wesolowski, John S.
    Jiang, Xuliang
    Lauder, Scott
    Sood, Vanita D.
    JOURNAL OF MOLECULAR RECOGNITION, 2015, 28 (04) : 269 - 276
  • [27] Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents
    Iris M. Hagemans
    Peter J. Wierstra
    Kas Steuten
    Janneke D. M. Molkenboer-Kuenen
    Duco van Dalen
    Martin ter Beest
    Johan M. S. van der Schoot
    Olga Ilina
    Martin Gotthardt
    Carl G. Figdor
    Ferenc A. Scheeren
    Sandra Heskamp
    Martijn Verdoes
    Journal of Nanobiotechnology, 20
  • [28] Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies
    Borch, Troels H.
    Donia, Marco
    Andersen, Mads H.
    Svane, Inge M.
    DRUG DISCOVERY TODAY, 2015, 20 (09) : 1127 - 1134
  • [29] Complete response with anti-PD-L1 antibody following progression on anti-PD-1 antibody in advanced non-small cell lung cancer
    Singh, Navdeep
    Seetharamu, Nagashree
    BMJ CASE REPORTS, 2020, 13 (08)
  • [30] Cimetidine Attenuates Therapeutic Effect of Anti-PD-1 and Anti-PD-L1 and Modulates Tumor Microenvironment in Colon Cancer
    Kuo, Feng-Chi
    Lai, Jerry Cheng-Yen
    Shieh, Hui-Ru
    Liou, Wan-Zu
    Bair, Ming-Jong
    Chen, Yu-Jen
    BIOMEDICINES, 2024, 12 (03)